Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-02-25 @ 4:39 PM
Study NCT ID:
NCT02665650
Status:
COMPLETED
Last Update Posted:
2019-05-16
First Post:
2016-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Sponsor:
Affimed GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05
Start Date Type:
None
Primary Completion Date:
2019-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-25
First Submit QC Date:
None
Study First Post Date:
2016-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-15
Last Update Post Date:
2019-05-16
Last Update Post Date Type:
ACTUAL